Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines

被引:19
|
作者
Somiya, Masaharu [1 ]
Mine, Sohtaro [2 ]
Yasukawa, Kosuke [3 ]
Ikeda, Saki [4 ]
机构
[1] Osaka Univ, Inst Sci & Ind Res, Mihogaoka 8-1, Ibaraki, Osaka 5670047, Japan
[2] NIAID, Med Virol Sect, Lab Infect Dis, NIH, 50 South DR, Bethesda, MD 20814 USA
[3] MedStar Washington Hosp Ctr, 110 Irving St NW, Washington, DC 20010 USA
[4] Baylor Coll Med, Dept Pediat, 1102 Bates Ave, Houston, TX 77030 USA
关键词
IMMEDIATE-TYPE HYPERSENSITIVITY; ANTIBODIES; PEG;
D O I
10.1016/j.vaccine.2021.04.066
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:3313 / 3314
页数:2
相关论文
共 50 条
  • [41] Brief review of the mRNA vaccines COVID-19
    Antonio Vitiello
    Francesco Ferrara
    Inflammopharmacology, 2021, 29 : 645 - 649
  • [42] mRNA vaccines do not stop with COVID-19
    Zhou, Jin
    Zhang, Yu
    Mo, Ke
    Newbert, Herbert
    Song, Xicheng
    LANCET, 2023, 402 (10401): : 526 - 526
  • [43] Boosting with updated COVID-19 mRNA vaccines
    Deepta Bhattacharya
    Gabriel D. Victora
    Nature Medicine, 2022, 28 : 2257 - 2258
  • [45] COVID-19 The overlooked superpower of mRNA vaccines
    Wadman, Meredith
    SCIENCE, 2021, 373 (6554) : 479 - 479
  • [46] Boosting with updated COVID-19 mRNA vaccines
    Bhattacharya, Deepta
    Victora, Gabriel D.
    NATURE MEDICINE, 2022, 28 (11) : 2257 - 2258
  • [47] The safety of Covid-19 mRNA vaccines: a review
    Pratibha Anand
    Vincent P. Stahel
    Patient Safety in Surgery, 15
  • [48] The dawn of mRNA vaccines: The COVID-19 case
    Verbeke, Rein
    Lentacker, Ine
    De Smedt, Stefaan C.
    Dewitte, Heleen
    JOURNAL OF CONTROLLED RELEASE, 2021, 333 : 511 - 520
  • [50] Validation of an HPLC-CAD Method for Determination of Lipid Content in LNP-Encapsulated COVID-19 mRNA Vaccines
    Yu, Xiaojuan
    Yu, Chuanfei
    Wu, Xiaohong
    Cui, Yu
    Liu, Xiaoda
    Jin, Yan
    Li, Yuhua
    Wang, Lan
    VACCINES, 2023, 11 (05)